Friedman Kaplan advised PAVmed Inc. and its majority-owned subsidiary Lucid Diagnostics Inc. on the public offering. Lucid Diagnostics Inc. (Nasdaq: LUCD), a commercial-stage, cancer prevention medical diagnostics…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Sonia Carcano
…
This content is for Standard 1 Year members only. LoginJoin Now